Ascendis Health Exits JSE and Positions for Growth

Ascendis Health has confirmed its plan to delist from the JSE in the first week of December, following an overwhelming mandate from its investors. This decision marks the culmination of the company’s significant turnaround strategy. Not long ago, it faced the...

Discovery Group’s Strong Growth Delivers 30% Profit Surge

Discovery Group has reported a robust financial performance for the year ending in June. It showcased the Discovery Group’s strong growth with a 30% increase in headline earnings to R9.6 billion. A key milestone in the results was Discovery Bank achieving its...

Novo Nordisk Hiring Freeze After Wegovy Sales Decline

Danish pharmaceutical giant Novo Nordisk, which rode a wave of unprecedented success with its weight-loss drug Wegovy, has announced a global hiring freeze for non-critical roles. This signals a dramatic shift from rapid expansion to rigorous cost-cutting. Sales begin...

NHI’s absence from budget raises questions about its future

While Budget 2025 covered numerous sectors, the notable absence of National Health Insurance (NHI) from Finance Minister Enoch Godongwana’s speech has sparked significant discussion. Despite its omission from the speech, references to NHI are present within the...